The Effect of Psychoeducation Program on Healthy Living Behaviors
NCT ID: NCT05208021
Last Updated: 2022-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2021-03-29
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Psychoeducation on Healthy Lifestyle Behaviors in Individuals With Schizophrenia
NCT05259748
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours
NCT06882538
The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia
NCT06820580
Motivational Interviewing in Patients With Schizophrenia
NCT04941352
Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia
NCT05449977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
"Health Promotion Model and the Motivational Interview-Based Health Protection and Promotion Program was applied to the intervention group
Intervention group (Motivational Interviewing)
The Health Promotion Model and the Motivational Interview-Based Health Protection and Promotion Program were applied to the experimental group, which consisted of 6 sessions and lasted an average of 60-120 minutes. Sessions were held in the form of individual interviews due to the pandemic and social distance conditions.
Control Group
Only data collection was carried out. No attempt was made by the researcher during the study
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention group (Motivational Interviewing)
The Health Promotion Model and the Motivational Interview-Based Health Protection and Promotion Program were applied to the experimental group, which consisted of 6 sessions and lasted an average of 60-120 minutes. Sessions were held in the form of individual interviews due to the pandemic and social distance conditions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with schizophrenia and other psychotic disorders for at least six months according to DSM-V diagnostic criteria,
* Registered with the Community Mental Health Center and coming regularly,
* Between the ages of 18-65,
* Who can read and write Turkish,
* Using antipsychotic medication for at least six months,
* Not in the "pre-thinking" stage in the change cycle stage,
* No skeletal, muscular, nervous system disease that prevents physical activity or healthy eating,
* They are patients without mental retardation, neurocognitive disorder, alcohol or substance abuse.
Exclusion Criteria
* Without a diagnosis of schizophrenia and other psychotic disorders,
* Not coming regularly to the Community Mental Health Center,
* Under 18 years old and over 65 years old,
* Does not speak Turkish,
* Not using regular antipsychotic medication,
* In the "pre-thinking" stage of the cycle of change,
* Those with skeletal, muscular, nervous system diseases that prevent physical activity or healthy nutrition,
* They are patients with mental retardation, neurocognitive disorder, alcohol and substance addiction.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahinur Betül Çalışkan
PhD student in nursing departman
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahinur Betül ÇALIŞKAN, MSc
Role: PRINCIPAL_INVESTIGATOR
Istanbul Saglik Bilimleri University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saglik Bilimleri Universitesi
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SY200217B08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.